«Berlin-based medical AI company Ada Health has announced the launch of a new partnership with Novartis in order to speed up the diagnosis for patients with immunological diseases and rare conditions.

The partnership will see Novartis use Ada Health’s AI-based, clinically validated, symptom assessment and care navigation solutions to help improve the identification and diagnosis of a number of diseases.»

Article written by  Sara Mageit



Mobi Health News